The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USA
Tóm tắt
Patients with chronic obstructive pulmonary disease (COPD) often have poor sleep quality and report a worsening of respiratory symptoms during night-time. However, current clinical guidelines for COPD management do not specifically consider nocturnal symptoms when recommending pharmacological treatment. This study aimed to better understand the burden of nocturnal symptoms in patients with COPD, and to evaluate the importance of nocturnal symptom control compared with daytime and overall symptom control. Data were analyzed from the Adelphi Respiratory Disease Specific Programme, a point-in-time survey of physicians and their patients, conducted in the USA in 2019. Primary care physicians and pulmonologists who managed three or more patients with COPD per month were eligible for inclusion; eligible patients were ≥ 18 years old, with a physician-confirmed diagnosis of COPD. Surveys from 171 physicians and 800 patients were analyzed. Everyday symptoms were reported in 14% of patients. In total, 88% of patients reported daytime symptoms, and 74% of patients experienced nocturnal symptoms, with 7% reporting daily nocturnal symptoms. Patients experiencing nocturnal symptoms every day had the greatest impairment in their activity as per the Work Productivity and Activity Impairment questionnaire (mean total activity impairment, 66.9%; nocturnal symptoms once or twice a week, 41.1%; no nocturnal symptoms, 26.4%). Patients experiencing daily nocturnal symptoms also had the lowest quality of life (QoL) as per the EuroQoL 5-Dimension 3-Level score. Physicians reported prescribing therapy based on sustained 24-h symptomatic relief for the majority of patients (78%). They reported nocturnal symptom control as a factor in their choice of therapy for 38% of patients, and daytime symptom control as a reason for 61% of patients. Daytime and nocturnal symptoms are common among patients with COPD. Frequency of nocturnal symptoms is related to a significant impairment in activity and health-related QoL.
Tài liệu tham khảo
Global Initiative for Chronic Obstructive Lung Disease. 2021 Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. 2021. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed 30 Sept 2021.
Agusti A, Hedner J, Marin J, Barbé F, Cazzola M, Rennard S. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(121):183–94. https://doi.org/10.1183/09059180.00004311.
Ding B, Small M, Bergström G, Holmgren U. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:589–99. https://doi.org/10.2147/COPD.S122485.
Kinsman RA, Yaroush R, Fernandez E, Dirks JF, Schocket M, Fukuhara J. Symptoms and experiences in chronic bronchitis and emphysema. Chest. 1983;83(5):755–61. https://doi.org/10.1378/chest.83.5.755.
Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax. 2009;64(2):133–8. https://doi.org/10.1136/thx.2007.088930.
Machado MC, Vollmer WM, Togeiro SM, et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J. 2010;35(1):132–7. https://doi.org/10.1183/09031936.00192008.
Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325–31. https://doi.org/10.1164/rccm.200912-1869OC.
Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes–a means to understand. Curr Med Res Opin. 2008;24(11):3063–72. https://doi.org/10.1185/03007990802457040.
Vestbo J, Vogelmeier C, Small M, Higgins V. Understanding the GOLD 2011 Strategy as applied to a real-world COPD population. Respir Med. 2014;108(5):729–36. https://doi.org/10.1016/j.rmed.2014.03.002.
Jenkins CD, Stanton B-A, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41(4):313–21. https://doi.org/10.1016/0895-4356(88)90138-2.
Lallukka T, Rahkonen O, Lahelma E, Arber S. Sleep complaints in middle-aged women and men: the contribution of working conditions and work–family conflicts. J Sleep Res. 2010;19(3):466–77. https://doi.org/10.1111/j.1365-2869.2010.00821.x.
Ferguson GT, Brown N, Compton C, et al. Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials. Respir Res. 2020;21:131. https://doi.org/10.1186/s12931-020-01360-w.
Omachi TA, Blanc PD, Claman DM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012;13(5):476–83. https://doi.org/10.1016/j.sleep.2011.12.007.
Shah A, Ayas N, Tan W-C, et al. Sleep quality and nocturnal symptoms in a community-based COPD cohort. COPD. 2020;17(1):40–8. https://doi.org/10.1080/15412555.2019.1695247.
Miravitlles M, Worth H, Cataluña JJS, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):122. https://doi.org/10.1186/s12931-014-0122-1.
Price D, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of night-time symptoms in COPD: a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis. 2013;8:595–603. https://doi.org/10.2147/COPD.S48570.
Saunders C, Byrne CD, Guthrie B, et al. External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med. 2013;30(3):300–8. https://doi.org/10.1111/dme.12047.
Hubbard TE, Paradis R. Real world evidence: a new era for health care innovation. The Network for Excellence in Health Innovation. 2015. https://www.nehi-us.org/writable/publication_files/file/rwe_issue_brief_final.pdf. Accessed 30 Sept 2021.